Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 488.00 | |
10 mg | In stock | $ 750.00 | |
25 mg | In stock | $ 1,470.00 | |
50 mg | In stock | $ 2,530.00 | |
100 mg | In stock | $ 3,970.00 |
Description | Bezuclastinib (CGT9486) is a novel, potent and highly selective tyrosine kinase and c-kit D816V inhibitor for the study of advanced mastocytosis. |
Synonyms | CGT9486, PLX 9486 |
Molecular Weight | 331.37 |
Formula | C19H17N5O |
CAS No. | 1616385-51-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 70 mg/mL (211.24 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bezuclastinib 1616385-51-3 Tyrosine Kinase/Adaptors c-Kit CGT9486 PLX 9486 inhibitor inhibit